KETOROLAC, A NEW NONOPIOID ANALGESIC - A DOUBLE-BLIND TRIAL VERSUS PENTAZOCINE IN CANCER PAIN

被引:22
作者
ESTAPE, J [1 ]
VINOLAS, N [1 ]
GONZALEZ, B [1 ]
INGLES, F [1 ]
BOFILL, T [1 ]
GUZMAN, MC [1 ]
TARRAGO, E [1 ]
机构
[1] SYNTEX LATINO SA,DEPT CLIN INVEST,BARCELONA,SPAIN
关键词
cancer pain; Ketorolac; pentazocine;
D O I
10.1177/030006059001800406
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A randomized double-blind trial was performed to evaluate the efficacy of a new non-steroidal anti-inflammatory analgesic drug, ketorolac, in the treatment of cancer pain compared with the opioid pentazocine. A total of 40 patients with moderate to severe cancer pain were studied, 20 patients being treated with 10 mg ketorolac given orally every 6 h and 20 receiving 50 mg pentazocine given orally every 6 h for up to 7 days. A reduction in the severity of the pain was recorded in both treatment groups with no significant difference in efficacy being found between the two therapies, although withdrawals due to adverse reactions were significantly less in the ketorolac-treated group (P < 0.005). It is concluded that ketorolac may be a useful and more acceptable alternative to opioids in the treatment of cancer pain. © 1990, SAGE Publications. All rights reserved.
引用
收藏
页码:298 / 304
页数:7
相关论文
共 14 条
  • [1] BLOOMFIELD SS, 1986, PHARMACOTHERAPY, V6, P247
  • [2] CARLSON RW, 1987, 5TH SAT S WORLD C PA
  • [3] EFFECTS OF KETOROLAC TROMETHAMINE ON HEMOSTASIS IN VOLUNTEERS
    CONRAD, KA
    FAGAN, TC
    MACKIE, MJ
    MAYSHAR, PV
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (05) : 542 - 546
  • [4] ESTENNE B, 1988, CURR THER RES CLIN E, V43, P1173
  • [5] GUZMAN A, 1986, J MED CHEM, V29, P589
  • [6] MCQUAY HJ, 1986, ACTA PHARMACOL TOX, V59, P324
  • [7] MONTOYAIRAHETA C, 1986, J CLIN PHARMACOL, V26, P545
  • [8] MROSZCZAK EJ, 1985, CLIN PHARMACOL THER, V37, P215
  • [9] MROSZCZAK EJ, 1987, DRUG METAB DISPOS, V15, P618
  • [10] PRESTON KL, 1987, J PHARMACOL EXP THER, V240, P900